Neurocrine Biosciences Inc <NBIX.O>: Morgan Stanley raises target price to $183.00 from $182.00
NBIX•Related News
Victory Capital reports August AUM of $356.47 billion
VCTR•
GameStop climbs after CEO Ryan Cohen discloses 1 mln share purchase
GME•
Black Rock Coffee Bar opens 22nd Colorado store in Highlands Ranch, Colorado
BRCB•
Apollo CEO Marc Rowan joins Bank of America Financials CEO Conference fireside chat
APO•
Fed seen likely to raise rates next week after inflation report
TLT•